{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/230382490"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "These case reports suggest that the risk of digoxin toxicity in patients with digoxin reduction products may be increased by factors such as the baseline serum concentration and other factors that influence digoxin metabolism and elimination, such as renal function, age and use of medications that can increase serum digoxin concentrations." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "aafp.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/386111101"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/230382490"] } } }
